Skin autofluorescence, a marker of advanced glycation end products and oxidative stress, is increased in recently preeclamptic women

American Journal of Obstetrics and Gynecology

Volumn 195, Issue 3, 2006, Pages 717-722

  Blaauw, Judith ^a,b   Smit, Andries J ^c   van Pampus, Maria G ^a   van Doormaal, Jasper J ^c   Aarnoudse, Jan G ^a   Rakhorst, Gerhard ^b   Graaff, Reindert ^b  

^a Departments of Obstetrics and Gynecology and Internal Medicine   (Netherlands)

^b Biomedical Engineering   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Advanced glycation end product; Atherosclerosis; Intima media thickness; Preeclampsia

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; LIPID;

ADULT; ARM; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; AUTOFLUORESCENCE; BLOOD PRESSURE MEASUREMENT; CAROTID ARTERY; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; CORRELATION ANALYSIS; DELIVERY; DISEASE MARKER; FEMALE; FEMORAL ARTERY; GROUPS BY AGE; HUMAN; HYPOTHESIS; INSULIN RESISTANCE; LEG; LINEAR REGRESSION ANALYSIS; LIPID ANALYSIS; MEASUREMENT; MEDICAL DOCUMENTATION; OXIDATIVE STRESS; PREECLAMPSIA; PRIORITY JOURNAL; SKIN MANIFESTATION; SMOKING HABIT;

ATHEROSCLEROSIS; ENDOTHELIUM, VASCULAR; FEMALE; FLUORESCENCE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INSULIN RESISTANCE; MATERNAL AGE; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; SKIN; TUNICA INTIMA; TUNICA MEDIA;

EID: 33747891801     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.06.086     Document Type: Article

References (22)

1. Irgens H.U., Reisaeter L., Irgens L.M., and Lie R.T. Long-term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 323 (2001) 1213-1217
2. Blaauw J., van Pampus M.G., van Doormaal J.J., Fokkema M.R., Fidler V., Smit A.J., et al. Increased intima-media thickness after early-onset preeclampsia. Obstet Gynecol 107 (2006) 1345-1351
3. Witztum J. The oxidation hypothesis of atherosclerosis. Lancet 344 (1994) 793-795
4. Hubel C.A. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 222 (1999) 222-235
5. Roberts J.M., and Hubel C.A. Is oxidative stress the link in the two-stage model of pre-eclampsia?. Lancet 354 (1999) 788-789
6. Thiele I.G., Niezen-Koning K.E., van Gennip A.H., and Aarnoudse J.G. Increased plasma carnitine concentrations in preeclampsia. Obstet Gynecol 103 (2004) 876-880
7. Schleicher E.D., Wagner E., and Nerlich A.G. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 99 (1997) 457-468
8. Bucciarelli L.G., Kaneko M., Ananthakrishnan R., Harja E., Lee L.K., Hwang Y.C., et al. Receptor for advanced-glycation end products. key modulator of myocardial ischemic injury. Circulation 113 (2006) 1226-1234
9. Cooke C.L., Brockelsby J.C., Baker P.N., and Davidge S.T. The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia. Hypertens Pregnancy 22 (2003) 173-184
10. Roberts J.M., and Redman C.W. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 341 (1993) 1447-1451
11. Blaauw J., Graaff R., van Pampus M.G., van Doormaal J.J., Smit A.J., Rakhorst G., et al. Abnormal endothelium-dependent microvascular reactivity in recently preeclamptic women. Obstet Gynecol 105 (2005) 626-632
12. Meerwaldt R., Graaff R., Oomen P.H., Links T.P., Jager J.J., Alderson N.L., et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 47 (2004) 1324-1330
13. Meerwaldt R., Hartog J.W., Graaff R., Huisman R.J., Links T.P., den Hollander N.C., et al. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 16 (2005) 3687-3693
14. Meerwaldt R., Links T.P., Graaff R., Hoogenberg K., Lefrandt J.D., Baynes J.W., et al. Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia 48 (2005) 1637-1644
15. Mulder D.J., van Haelst P.L., Graaff R., Smit A.J., Gans R.O.B., and Zijlstra F. Skin autofluorescence is an independent marker for acute myocardial infarction. Circulation 112 (2005) II-371
16. Davey D.A., and MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 158 (1988) 892-898
17. D'Orazio P., Burnett R.W., Fogh-Andersen N., Jacobs E., Kuwa K., Kulpmann W.R., et al. International Federation of Clinical Chemistry Scientific Division Working Group on selective electrodes and point of care testing: approved IFCC recommendation on reporting results for blood glucose (abbreviated). Clin Chem 51 (2005) 1573-1576
18. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
19. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 28 suppl (2005) S4-S36
20. Zieman S.J., and Kass D.A. Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease. Drugs 64 (2004) 459-470
21. Sattar N., Ramsay J., Crawford L., Cheyne H., and Greer I.A. Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension 42 (2003) 39-42
22. Chambers J.C., Fusi L., Malik I.S., Haskard D.O., de Swiet M., and Kooner J.S. Association of maternal endothelial dysfunction with preeclampsia. JAMA 285 (2001) 1607-1612